{"database": "openregs", "table": "documents", "rows": [["FDA-2018-N-4845-0001", "FDA", "FDA-2018-N-4845", "Amendments to the List of Bulk Drug Substances That Can Be Used to\nCompound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2019-09-05T04:00:00Z", 2019, 9, "2019-09-05T04:00:00Z", "2019-12-05T04:59:59Z", "2019-12-06T02:01:33Z", "2019-18951", 0, 0, "0900006483eed96e"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2018-N-4845-0001"], "units": {}, "query_ms": 0.9716619970276952, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}